Taiai Peptide Group adheres to technological innovation and research and development as its core strength. Over the years, based on the group's commitment to independent research and development, it has maintained long-term cooperative relationships with many important domestic and foreign scientific research institutions and efficiently.
We have developed eight patented technologies for the preparation and production of small molecule peptides, including four national invention patents and multiple national utility model patents.
Taiai Peptide Group has an experienced and skilled R&D team, consisting of doctors, masters, and industry experts. Currently, the R&D team has more than 60 members, including several elite teams with master's degrees in biotechnology or above and more than eight years of experience in the industry.
In 2023, Taiai Peptide Group and Hebei University will join forces to achieve deep cooperation in patent application, academic exchange, project application and other fields, forming complementary advantages between industry, academia and research, promoting the transformation of more scientific and technological achievements, and jointly pushing the development of China's bioactive peptide industry to a new level!
In 2022, Taiai Peptide Group and "Jiangnan University" jointly established the Taimei Joint R&D Center.
For the application of small molecule peptide technology in herbaceous plants, the unique technical advantages of Taiai Peptide provide technical guarantees for the raw materials used in this project. With the advantages of traditional Chinese medicine theory and clinical application, referring to the application of Japanese Hanfang preparations, Taiai Peptide plant small molecule raw materials are used as the formula. With complete clinical data, the essence of traditional Chinese medicine from China for 5000 years is transformed into market value and social value.
●Clinical Medicine major at China Medical University
●National Pharmacist Qualification, National Senior Nutritionist
●Peptide Science Popularization and Public Welfare Promotion Ambassador of Peptide and Health Industry Branch of China Health Association
●Vice Dean of the School of Life Sciences, Beijing University of Traditional Chinese Medicine
●Joint cultivation of doctors by the Chinese Academy of Sciences and the Max Planck Institute of Germany
●Dual PhD in Traditional Chinese Medicine and Clinical Nutrition
●Doctor of Science (later), Professor, Doctor of Science
●Deputy Director of the Comprehensive Experimental Center of Hebei University
●Doctor of Public Health
●Associate Researcher at the Chinese Academy of Agricultural Sciences
.png)
●PhD and Associate Professor, Department of Biochemistry, Purdue University, USA
●Designer and implementer of the National Institutes of Health (NIH R01 project) project in the United States
